![Michael Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kelly
Director Técnico/Científico/I+D en
CureDuchenne
.
Perfil
Michael G.
Kelly is currently the Director at Trinds LLC since 2017 and the Chief Scientific Officer at CureDuchenne since 2011.
Previously, he worked as the President, Chief Executive Officer & Director at MyoTherix, Inc. He was also the Research Director at Amgen, Inc. from 1999 to 2000.
Additionally, he worked as a Director at NeoGenesis Pharmaceuticals, Inc. and as the Senior Vice President-Research & Development at Renovis, Inc. Dr. Kelly holds a doctorate degree from The University of Southampton and an undergraduate degree from the University of Ulster.
Cargos activos de Michael Kelly
| Empresas | Cargo | Inicio |
|---|---|---|
CureDuchenne
 CureDuchenne Financial ConglomeratesFinance Provides funding for research projects | Director Técnico/Científico/I+D | 13/12/2011 |
Trinds LLC
 Trinds LLC Miscellaneous Commercial ServicesCommercial Services Operates as a research organization for neuromuscular diseases | Director/Miembro de la Junta | 01/11/2017 |
Antiguos cargos conocidos de Michael Kelly.
| Empresas | Cargo | Fin |
|---|---|---|
| AMGEN INC. | Director Técnico/Científico/I+D | 01/01/2000 |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director Técnico/Científico/I+D | - |
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Director/Miembro de la Junta | - |
MyoTherix, Inc.
 MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Director Ejecutivo | - |
Formación de Michael Kelly.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
42
Relaciones de 1er grado
8
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Health Technology |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Ulster
 University of Ulster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance Provides funding for research projects | Finance |
MyoTherix, Inc.
MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Health Technology |
Trinds LLC
Trinds LLC Miscellaneous Commercial ServicesCommercial Services Operates as a research organization for neuromuscular diseases | Commercial Services |
- Bolsa de valores
- Insiders
- Michael Kelly
Elige MarketScreener 
